Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric

Recruiting N/A Interventional Study
Age Related Cataracts Astigmatism
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 95
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
750 (estimated)
Sponsor
Medical University of Vienna · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The investigational devices are approved intraocular lenses (IOL) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Within the study, three different IOLs will be investigated and separately evaluated. Cataract surgery with IOL implantation will be performed in subjects who have signed an informed consent form. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Uni- or bilateral age-related cataract necessitating phacoemulsification extraction and posterior IOL implantation * Age: 45 to 95 * Need for spherical IOL correction between 10.00 and 30.00 D * Need for spherical IOL correction between +6.00 and +30.00 D (Alcon Clareon toric …
Contacts

Rupert Menapace, Prof.Dr.

0043-1-40400

rupert.menapace@meduniwien.ac.at

CONTACT

Daniel Schartmueller, Dr.

0043-1-40400

daniel.schartmueller@meduniwien.ac.at

CONTACT